Sternberg CN, Saad F, Graff JN, Peer A, Vaishampayan UN, Leung E, Rosenbaum E, Gurney H, Epstein RJ, Davis ID et al..
2020.
A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer.. Ann Oncol. 31(2):257-265.
Abida W, Patnaik A, Campbell D, Shapiro J, Bryce AH, McDermott R, Sautois B, Vogelzang NJ, Bambury RM, Voog E et al..
2020.
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a or Gene Alteration.. J Clin Oncol. 38(32):3763-3772.
Rimel JK, Poss ZC, Erickson B, Maas ZL, Ebmeier CC, Johnson JL, Decker T-M, Yaron TM, Bradley MJ, Hamman KB et al..
2020.
Selective inhibition of CDK7 reveals high-confidence targets and new models for TFIIH function in transcription.. Genes Dev. 34(21-22):1452-1473.
De Micheli AJ, Laurilliard EJ, Heinke CL, Ravichandran H, Fraczek P, Soueid-Baumgarten S, De Vlaminck I, Elemento O, Cosgrove BD.
2020.
Single-Cell Analysis of the Muscle Stem Cell Hierarchy Identifies Heterotypic Communication Signals Involved in Skeletal Muscle Regeneration.. Cell Rep. 30(10):3583-3595.e5.
Venturutti L, Teater M, Zhai A, Chadburn A, Babiker L, Kim D, Béguelin W, Lee TC, Kim Y, Chin CR et al..
2020.
TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate.. Cell. 182(2):297-316.e27.
Vanmeerbeek I, Sprooten J, De Ruysscher D, Tejpar S, Vandenberghe P, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L et al..
2020.
Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology.. Oncoimmunology. 9(1):1703449.
Frega G, Wu Q, Le Naour J, Vacchelli E, Galluzzi L, Kroemer G, Kepp O.
2020.
Trial Watch: experimental TLR7/TLR8 agonists for oncological indications.. Oncoimmunology. 9(1):1796002.
Le Naour J, Galluzzi L, Zitvogel L, Kroemer G, Vacchelli E.
2020.
Trial watch: IDO inhibitors in cancer therapy.. Oncoimmunology. 9(1):1777625.
Le Naour J, Zitvogel L, Galluzzi L, Vacchelli E, Kroemer G.
2020.
Trial watch: STING agonists in cancer therapy.. Oncoimmunology. 9(1):1777624.
Le Naour J, Galluzzi L, Zitvogel L, Kroemer G, Vacchelli E.
2020.
Trial watch: TLR3 agonists in cancer therapy.. Oncoimmunology. 9(1):1771143.
Pine AR, Cirigliano SM, Nicholson JG, Hu Y, Linkous A, Miyaguchi K, Edwards L, Singhania R, Schwartz TH, Ramakrishna R et al..
2020.
Tumor Microenvironment Is Critical for the Maintenance of Cellular States Found in Primary Glioblastomas.. Cancer Discov. 10(7):964-979.